Nath Bio-Genes (India) Limited, a leading player in the seed industry, has reported a robust financial performance for the second quarter of fiscal year 2026. The company's revenue witnessed a significant growth of 23.5% year-on-year, reaching Rs 398 million, driven by strong performances in its cotton and vegetable seeds segments.

Key Highlights

• Revenue increased by 23.5% to Rs 398 million in Q2FY26
• Profit After Tax (PAT) grew by 45.4% to Rs 42 million
• Gross margins expanded to 68% from 60% in the previous year
• Cotton segment saw a 6.3% growth to 1.11 million packets
• Vegetable seeds segment recorded a 24.4% growth

Segment-wise Performance

Cotton Segment

The cotton segment, which continues to be the key revenue driver for Nath Bio-Genes, reported a 6.3% year-on-year rise to 1.11 million packets. This steady performance reflects resilient demand and the company's strong channel presence in the market.

Vegetable Seeds Segment

The vegetable seeds segment emerged as the fastest-growing category for Nath Bio-Genes, delivering a robust 24.4% year-on-year growth. This segment's strong performance is attributed to expanding market reach and increasing farmer demand, contributing positively to the company's revenue mix and margin accretion.

Other Crop Segments

Financial Performance

Nath Bio-Genes' profit after tax (PAT) saw a substantial increase of 45.4%, reaching Rs 42 million in Q2FY26. This growth in profitability was supported by an expansion in gross margins, which improved from 60% in the previous year to 68% in the current quarter.

The company's improved financial performance can be attributed to its strategic focus on diversification beyond cotton and accelerated growth in high-margin products. Nath Bio-Genes is also emphasizing operational efficiency enhancement and strengthening innovation through focused R&D efforts.

International Collaboration

The company's joint venture in Uzbekistan is operating successfully, strengthening its ongoing business momentum and international presence. This collaboration is expected to contribute to Nath Bio-Genes' growth strategy in the coming quarters.

Outlook

With a strong performance in Q2FY26, Nath Bio-Genes appears well-positioned to capitalize on the growing demand for high-quality seeds in both domestic and international markets. The company's focus on diversification, R&D, and operational efficiency is likely to drive sustainable growth in the future.

Nath Bio-Genes (India) Limited, a leading player in the seed industry, has announced its financial results for the first quarter of the fiscal year 2025-26, showcasing robust growth in both revenue and profitability.

Financial Highlights

• Revenue Growth: The company reported a significant increase in revenue for Q1 FY2026, rising to ₹280.17 crore from ₹243.88 crore in the same period last year, marking a 14.9% year-over-year growth.
• Profit Surge: Net profit for the quarter stood at ₹38.21 crore, up from ₹33.89 crore in Q1 of the previous fiscal year, representing a 12.7% increase.
• Operating Performance: Nath Bio-Genes demonstrated strong operational efficiency, with profit from operations before other income, finance cost, and exceptional items reaching ₹37.93 crore, compared to ₹36.23 crore in the corresponding quarter of the previous year.

Key Financial Metrics

Management Commentary

While specific management comments were not provided, the strong financial performance reflects the company's continued focus on growth and operational excellence in the competitive seed industry.

Board Meeting Outcomes

In addition to approving the financial results, the Board of Directors, at its meeting held on July 11, 2025, made the following key decision:

• New Independent Director: The Board approved the appointment of Ms. Payal Jain as an Additional Director (to be appointed as Independent Director subject to shareholder approval at the upcoming Annual General Meeting).

About Ms. Payal Jain

Ms. Payal Jain brings over 15 years of professional experience to the board, including:

• Expertise in sales, negotiations, business development, and project management
• 5 years of experience in real estate
• Currently serving as Project Head - Sales at Kushal Wallstreet
• Qualified Company Secretary with a strong legal and compliance background

The appointment of Ms. Jain is expected to bring valuable insights and expertise to Nath Bio-Genes' board, particularly in areas of compliance and business development.

Nath Bio-Genes' strong Q1 performance sets a positive tone for the fiscal year 2025-26, reflecting the company's resilience and growth potential in the seed industry. Investors and stakeholders will be keenly watching the company's performance in the coming quarters to see if this growth momentum continues.